A recent study completed at Roswell Park Cancer Institute is helping redefine how we use the PSA (prostate-specific antigen) test for prostate cancer patients by demonstrating that even when PSA is present, the levels of the marker can be a key indicator of what treatment is necessary-or unnecessary.
Read more: goo.gl/kkPLfW
4 окт 2024